EKTAY (Elekta AB) Other Current Receivables: $255 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EKTAY Elekta AB EKTAY
74 GF Score
Price $4.74
GF Value $6.51
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elekta AB Other Current Receivables?

Elekta AB EKTAY 74 Other Current Receivables is $255 Mil as of Apr. 2026. GuruFocus rates EKTAY with a GF Score™ of 74/100 and a GF Value™ of $6.51 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Elekta AB's Other Current Receivables for the quarter that ended in Apr. 2026 was $255 Mil.

Elekta AB's quarterly Other Current Receivables declined from Oct. 2025 ($429.48 Mil) to Jan. 2026 ($406.94 Mil) but then stayed the same from Jan. 2026 ($406.94 Mil) to Apr. 2026 ($255.37 Mil).

Elekta AB's annual Other Current Receivables increased from Apr. 2024 ($258.14 Mil) to Apr. 2025 ($301.58 Mil) but then declined from Apr. 2025 ($301.58 Mil) to Apr. 2026 ($255.37 Mil).

Elekta AB Other Current Receivables Related Terms

Elekta AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Elekta AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB Other Current Receivables Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 259.87 274.15 258.14 301.58 255.37

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.58 425.32 429.48 406.94 255.37
EKTAY
74GF Score
Elekta AB EKTAY
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $255 Mil mean?
Elekta AB (EKTAY) has a Other Current Receivables of $255 Mil as of Apr. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Elekta AB and its competitors.
Is Elekta AB's Other Current Receivables too high?
Elekta AB's current Other Current Receivables is $255 Mil. Overall, Elekta AB has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Other Current Receivables compare to ABT and SYK?
Elekta AB's Other Current Receivables of $255 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Elekta AB and its competitors. Elekta AB's current Other Current Receivables is $255 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAY) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.51, compared to a current price of $4.74 — trading 27.2% below its estimated fair value. The current Other Current Receivables is $255 Mil. Elekta AB's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Elekta AB (EKTAY), the current Other Current Receivables is $255 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (EKTAY) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of $4.74 is trading 27.2% below its estimated GF Value™ of $6.51. GuruFocus considers Elekta AB to be Modestly Undervalued.

Key valuation signals for EKTAY:

  • Other Current Receivables: $255 Mil
  • GF Value™: $6.51 vs. price of $4.74 (27.2% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the EKTAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
74GF Score

Get the complete analysis for EKTAY

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.74
Price
$6.51
GF Value